Display options
Share it on

J Clin Med. 2020 Jun 30;9(7). doi: 10.3390/jcm9072055.

Mild Cognitive Impairment Subtypes and Type 2 Diabetes in Elderly Subjects.

Journal of clinical medicine

Silvia Valenza, Lucia Paciaroni, Susy Paolini, Anna Rita Bonfigli, Mirko Di Rosa, Rosa Anna Rabini, Elena Tortato, Paolo Pelliccioni, Giuseppe Pelliccioni

Affiliations

  1. Neurology Department, Italian National Research Center on Aging (IRCCS INRCA), 60100 Ancona, Italy.
  2. Psychology Department, Azienda Ospedaliera Ospedali Riuniti Marche Nord, 61121 Pesaro-Fano, Italy.
  3. Scientific Direction, Italian National Research Center on Aging (IRCCS INRCA), 60100 Ancona, Italy.
  4. Unit of Geriatric Pharmacoepidemiology and Biostatistics, Italian National Research Center on Aging (IRCCS INRCA), 60124 Ancona, Italy.
  5. Metabolic Diseases and Diabetology Department, Italian National Research Center on Aging (IRCCS INRCA), 60100 Ancona, Italy.
  6. Eye Clinic, Polytechnic University of Marche, 60126 Ancona, Italy.

PMID: 32629878 PMCID: PMC7408775 DOI: 10.3390/jcm9072055

Abstract

BACKGROUND: Type 2 diabetes (T2D) is correlated to amnestic mild cognitive impairment (aMCI) and to non-amnestic mild cognitive impairment (naMCI). This study evaluated whether the T2D variable characterizes a peculiar cognitive profile in elderly patients. Moreover, it explores the association between glycated hemoglobin levels (HbA1c), T2D duration, insulin and oral hypoglycemic agent treatment, and cognition in elderly diabetic patients.

METHODS: Detailed neuropsychological battery was used to diagnose MCI subtypes. A total of 39 MCI subjects with T2D (T2D-MCI) and 37 MCI subjects without T2D (ND-MCI), matched for age, educational level, and Mini-Mental State Examination score, were included.

RESULTS: ND-MCI performed worse in memory and language domains than T2D-MCI. The amnestic subtype is more frequent among ND-MCI and non-amnestic subtype in T2D-MCI. In T2D-MCI, high HbA1c levels correlate with episodic memory (immediate recall) and T2D duration. Some indexes of episodic memory (immediate recall), attention, and visual-spatial ability correlate with insulin treatment.

CONCLUSIONS: An association between T2D and non-amnestic MCI is suggested. In the T2D-MCI group, significant associations between insulin treatment and memory (immediate recall), complex figure copy, and attention were found.

Keywords: Alzheimer’s disease; aging; cognitive functions; dementia; mild cognitive impairment; neuropsychological test; type 2 diabetes

References

  1. Lancet Neurol. 2007 Aug;6(8):734-46 - PubMed
  2. Curr Neuropharmacol. 2011 Dec;9(4):693-705 - PubMed
  3. Arch Clin Neuropsychol. 2019 Jan 24;35(1):22-30 - PubMed
  4. J Biol Chem. 1994 Mar 18;269(11):8445-54 - PubMed
  5. Brain. 2001 Apr;124(Pt 4):731-8 - PubMed
  6. Eur Neurol. 1996;36(6):378-84 - PubMed
  7. Neurology. 1999 Dec 10;53(9):1937-42 - PubMed
  8. Diabetes Res Clin Pract. 2015 Aug;109(2):299-305 - PubMed
  9. Lancet Neurol. 2004 Mar;3(3):169-78 - PubMed
  10. Dement Neuropsychol. 2017 Oct-Dec;11(4):406-412 - PubMed
  11. Diabetes. 2002 Apr;51(4):1256-62 - PubMed
  12. J Intern Med. 2004 Sep;256(3):240-6 - PubMed
  13. Arch Neurol. 2008 Aug;65(8):1066-73 - PubMed
  14. Neurol Sci. 2011 Dec;32(6):1057-62 - PubMed
  15. Arch Neurol. 2007 Apr;64(4):570-5 - PubMed
  16. J Psychiatr Res. 1975 Nov;12(3):189-98 - PubMed
  17. Neurobiol Aging. 2001 Jul-Aug;22(4):529-39 - PubMed
  18. Am J Alzheimers Dis Other Demen. 2012 Aug;27(5):321-30 - PubMed
  19. Br J Psychiatry. 2010 Jan;196(1):36-40 - PubMed
  20. J Am Geriatr Soc. 2019 Feb;67(2):232-238 - PubMed
  21. J Diabetes Complications. 2017 Aug;31(8):1272-1274 - PubMed
  22. J Mol Neurosci. 2019 Jun;68(2):251-260 - PubMed
  23. Aging Clin Exp Res. 2002 Apr;14(2):117-31 - PubMed
  24. Neurol Sci. 2000 Oct;21(5):279-91 - PubMed
  25. J Am Geriatr Soc. 2017 Oct;65(10):2198-2204 - PubMed
  26. J Intern Med. 2004 Sep;256(3):183-94 - PubMed
  27. JAMA. 1963 Sep 21;185:914-9 - PubMed
  28. Neurol Sci. 2013 Jun;34(6):985-93 - PubMed
  29. Neurol Sci. 2014 Mar;35(3):365-72 - PubMed
  30. Gerontologist. 1969 Autumn;9(3):179-86 - PubMed
  31. Nat Rev Endocrinol. 2018 Oct;14(10):591-604 - PubMed
  32. J Alzheimers Dis. 2015;43(4):1441-9 - PubMed
  33. Int J Alzheimers Dis. 2012;2012:936272 - PubMed
  34. FASEB J. 2008 Jan;22(1):246-60 - PubMed
  35. Alzheimers Dement. 2014 Jan;10(1):18-26 - PubMed
  36. Lancet Neurol. 2003 Sep;2(9):548-54 - PubMed
  37. Diabetologia. 2005 Dec;48(12):2460-9 - PubMed
  38. Am J Epidemiol. 2001 Oct 1;154(7):635-41 - PubMed
  39. Neurol Sci. 2013 May;34(5):749-54 - PubMed
  40. J Alzheimers Dis. 2014;42(4):1269-77 - PubMed
  41. Neurol Sci. 2011 Dec;32(6):1081-9 - PubMed
  42. Can J Diabetes. 2017 Feb;41(1):114-119 - PubMed
  43. BMJ Open. 2017 Aug 4;7(8):e016390 - PubMed
  44. Diabetes Care. 2008 Nov;31(11):2103-7 - PubMed
  45. Front Neurosci. 2018 Nov 13;12:830 - PubMed
  46. Neuropsychology. 2009 Jan;23(1):1-9 - PubMed
  47. J Diabetes Sci Technol. 2008 Nov;2(6):1101-13 - PubMed
  48. Rev Neurosci. 2017 Oct 26;28(7):715-723 - PubMed
  49. Int Psychogeriatr. 2008 Feb;20(1):96-108 - PubMed
  50. Neurol Sci. 2005 Jun;26(2):108-16 - PubMed

Publication Types